Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 8/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 4/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | GFER | P55789 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23600770 | 0.93 | EPHX2 (0.40) | EPHX2NPC1LMNAMAPTALDH1A1 | |
| SCHEMBL23600813 | 0.90 | NPC1 (0.41) | EPHX2NPC1LMNAMAPTALDH1A1 | |
| SCHEMBL25125100 | 0.87 | EPHX2 (0.36) | EPHX2NPC1LMNAMAPTALDH1A1 | |
| SCHEMBL23600761 | 0.86 | EPHX2 (0.31) | EPHX2LMNA | |
| SCHEMBL25125417 | 0.82 | LMNA (0.38) | EPHX2NPC1LMNAMAPTALDH1A1 | |
| SCHEMBL25124742 | 0.82 | PDK2 (0.37) | MAPTSMN1; SMN2 | |
| SCHEMBL30132954 | 0.82 | FABP3 (0.39) | LMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL15892493 | 0.82 | FABP3 (0.39) | LMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL23057431 | 0.81 | EPHX2 (0.43) | EPHX2NPC1LMNAMAPTALDH1A1 | |
| SCHEMBL22815548 | 0.81 | NPC1 (0.44) | EPHX2NPC1LMNAMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021134820-A1 | NEW ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE | 南京高光半导体材料有限公司 | 2021-07-08 | — | — | WO | disclosed |
| US-20210202843-A1 | NOVEL ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE | NANJING TOPTO SEMICONDUCTOR MATERIAL CO., LTD. (CN) | 2021-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210202843-A1 | NOVEL ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE | L1CAM, C1S, H1-10 | EPHX2 761/4885NPC1 3132/4885LMNA 522/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.